Penis Extender
- Permanent Results
- More Length: 3 to 5 cm (1" to 2")
- More Girth: 1 cm (0.4")
- 100% Effective
Calculate Your Size |
 |
 Guarantees
Andro-Penis�, classified as a Medical Device Type 1 by the European
Health Authorities, has the CE sign
Andromedical is UNE-EN-ISO 9001: 2000 certified.
- Health Certifications
- Quality Certification
|
|
Penile
enlargement without surgery with the Andro-Penis�
Scientific Research presented in
the 1st Virtual Sexology and Hispanoamerican Sexual Education Congress
(February -2001)
Dr. Eduardo A. Gomez de Diego „ 1998 Andrology Services ,Andromedical
Clinic, Madrid (Spain)
1. Introduction:
When the human tissues are submitted to a
force of traction, they react by increasing in size.
The principle of traction is applied in modern medicine, for the generation
of new tissue to cover burn wounds or areas of hair loss ( placing
a tissular expander underneath the normal skin ) or for the lenghthening
of bones.
In other cultures this principle is applied to lenghthen different
parts of the body like the Giraffe Women of the Paduang tribe in Birmania
; or the lenghthening of the lips in certain African tribes of Africa
that use wood to create traction; and in India where they hang stones
on the penis of men as a form of penitence with the resulting enlargement
of the organ.
Based on this principle of external traction the Andro-Penis®
was designed . It is able to exhert a gradual traction force of 600
to 1500 grams.
The device consists of a plastic ring, where the penis is introduced
and from where 2 dynamic metalic rods that originate the traction.
In the superior part there is a plastic support where a silicone band
holds the glans in place.
Based on our clinical experience the traction
device yields the following resutls:
- An increase in the lenght of the penis in
erection and flaccidity.
- An increase in the perimeter of the penis
in erection and flaccidity.
- This results will be analyzed statistically
to be verified and quantified
2. Materials and Methods
Number
of patients: 37 patients, ages between 22 and 60 years of
age. These men proceed from different cities in Spain.
Selection
of patients: patients included were healthy men with normal
erection capabilities and without penile surgeries. Patients with
penile or other diseases where excluded from the studies.
Traction
device: The Andro-Penis®, German penile traction device.
Traction
Force: 600 gr during 1st month, 900 gr during 2nd month, 1100
gr durante 3th and 4th mes, and 1200 gr during 5th y 6th month.
Usage
period: 10 hours a day, during every day of the month for
a period of 3-6 months.
3. Results
3.1.-
INCREASE IN LENGHT IN ERECTION:
The increase in
the length of the penis in erection, is relative to the length of
time in which the device is worn. Such growth is lineal as is observed
in the chart. This translates in: the longer the time of use, the
more lenght is obtained.
The lineal correlation coefficient between time of use and increase
in length in erection is of 0.760 ( p=0.000 ).
The average increase in
the length of the penis in erection by month is of 0.4726 cm. The
standard deviation is of 0.1329 cm. The confidential interval of
95% is of [0.4283 ; 0.5169] which indicates a minimal gain in the
population of 0.4283 cm/month.
Regression line is:
DL erec = - 0.327 + 0.562 x t
This calculation will allow us to estimate the increase in length
of the penis in erection, based on the months of use of the device.
There is a 57.7% variance in the increment in longitude, which is
explained by the variance in the duration of treatment ( R2= 0.577
). The other 42.3% is due to other differences innate to each individual
and not relative to the duration of the treatment
3.2.- INCREMENT IN LENGTH IN THE FLACCID
STATE
The increment in length
in the flaccid state is relative to the time of usage of the device.
Such an increment is linear as shown in the graph. The longer the
device is used, the greater the increase in length. The coefficient
of the linear correlation between the time of usage and the increment
in longitude in the flaccid state is of 0.725 ( p=0.000 ).
The average monthly increment
in longitude of the penis in the flaccid state is 0.4834 cm and
the typical deviation is 0.1983 cm. The confidence interval of 95%
is of [0.4173 ; 0.5495] and indicates a minimum increase in the
population of 0.4173 cm/month.
Regression line is:
DL flac = - 1.300 + 0.840 x t
This calculation allows us to estimate the increment in longitude
in the flaccid state based on the months in which the device is
used. There is a 52.5% variance in the increment in longitud which
is explained by the variance of the duration of treatment ( R2=
0.525 ). The other 47.5% is due to other differences innates to
the individual and not relative to the duration of the treatment.
3.3.- VARIABILITY:
The variability in the increment
in longitude in erection is different from that of flaccidity, being
the difference in variance significant ( p= 0.003 ) which indicates
a greater dispersion of the increases in length during flacidity
than in erection.
3.4.- THE INCREMENT IN LONGITUDE DOES NOT
DEPEND ON THE AGE:
A very interesting result
was that the increment in longitude does not depend on the age of
the patient, since the coefficient of the linear correlation is
not significant ( r=0.008, p=0.961). In other words, the age of
the patient does not effect the increment in longitude.
3.7.-
LONGITUDE INCREASE IN ERECTION STATE DEPENDING ON USE:
Dividing the population
studied in four sub groups depending on the usage time of the Andro-Penis®.
we obtain the following results.
Three months usage:
The median longitude increment in erection state was 1.4118, obtaining
a median growth of 10.5580% over the initial longitude.The confidence
interval of 95% of the studied population was ( 1.1522; 1.6713)
which shows a median minimal growth of 1.1522 cm in three months.
Four months usage:
The median longitude increment in erection state was 1.8462, obtaining
a median growth of 14.1113% over the initial longitude. The confidence
interval of 95% of the studied population was(1.5809; 2.1114) which
shows a median minimal growth of 1.5809 cm in four months.
Five months usage:
The median longitude increment in erection state was 2.2750, obtaining
a median growth of 16.6303% over the initial longitude. The confidence
interval of 95% of the population studied was (1.7656; 2.7844) which
shows a median minimal growth of 1.7656 cm in four months.
Six months usage:
The median longitude increment in erection state was 3.3333, obtaining
a median growth of 27.5% over the initial longitude. The confidential
interval of 95% of the population studied was (2.8162; 3.8504) which
shows a median minimal growth of 2.8162 cm in six months.
The samples corresponding to five and six months are very small
which makes small intervals and less reliable.
3.8.- DISTRIBUTION:
Although the variables considered
in the population are not normal, the median samples, have normal
distribution since the amount of the sample is greater than 20.
3.9.- ABBREVIATIONS:
| Inc-Long-Erec |
Longitude
increment in erection state |
| DL
erec |
Change
in Longitude increment in erection state |
| I.L.ERT |
Longitude
increment in erection as a function of the time variable |
| I.L.FLAC |
Longitude
increment in flaccid state |
| DL
flac |
Change
in Longitude increment in flaccid state |
| I.L.FLT |
Longitude
increment in flaccid state in function of time |
| Inc-Long-Erec |
Longitude
increment in erection state |
| %
I Long-Erec |
Longitude
increment percentage in erection state. |
4. Conclusions
The use of the German traction
device ( Andro-Penis ) will increase the length of the penis, both
in the erectile and flaccid state.
The increase in length, both in
and flaccidity, is directly proportional to the time of use.
The increse in length both in
erection and flaccidity, does not depend on the natural size of
the patient.
The average growth in length of
the penis in cm/month in 95% of the patients was between 0.4283
and 0.5163 in erection, and between 0.4173and 0.5495 in flaccidity.
The increments of change in length
of the penis in erection are more uniform than those in flaccidity
which tend to be more disparate .
The increment of change in the
length of the penis in erection is not relative to the age of the
patient.
The use of the penile traction
device will increase the perimeter of the penis, both in erection
and flaccidity.
The average growth in perimeter
in cm/month in 95% of the patients was between 0.6111 and 1.0200
in erection, and between 0.6386 and 1.0425 in flaccidity. Treatment
was 3-6 months duration.
5. Anex
 PATIENT
RESULTS (Using the Andro-Penis®):
| Nombre |
Edad
|
Inicio
|
L-Erec1
|
L-Flac1
|
P-Erec1
|
P-Flac1
|
Meses
|
L-Erec2
|
L-Flac2
|
P-Erec2
|
P-Flac2
|
| LAA
|
60
|
15.1.98
|
12.0
|
8.0
|
12.0
|
10.0
|
3.0
|
13.5
|
9.0
|
13.5
|
10.5
|
| EAG
|
37
|
30.1.98
|
14.5
|
8.0
|
12.0
|
8.5
|
4.0
|
16.5
|
9.5
|
13.0
|
10.5
|
| VA
|
27
|
26.11.97
|
16.3
|
10.4
|
13.9
|
10.1
|
3.0
|
17.8
|
12.5
|
14.5
|
11.5
|
| EAA
|
46
|
15.3.98
|
14.5
|
10.5
|
12.0
|
10.0
|
6.0
|
17.6
|
15.7
|
13.2
|
11.2
|
| JBV
|
25
|
27.3.98
|
15.0
|
8.0
|
13.0
|
9.0
|
3.0
|
16.6
|
9.5
|
13.3
|
10.5
|
| ABB
|
39
|
29.6.98
|
14.0
|
11.0
|
13.0
|
11.0
|
3.0
|
15.5
|
12.5
|
14.0
|
12.0
|
|
CBG
|
37
|
19.1.98
|
12.5
|
6.0
|
12.0
|
9.0
|
4.0
|
14.0
|
8.8
|
12.5
|
9.4
|
|
JBL
|
25
|
7.5.98
|
13.7
|
9.0
|
11.5
|
10.0
|
4.0
|
16.3
|
11.5
|
13.5
|
12.0
|
| JCB
|
27
|
19.11.97
|
13.0
|
8.0
|
14.5
|
12.0
|
6.0
|
16.4
|
11.1
|
14.2
|
12.2
|
| JJCA
|
33
|
1.6.98
|
10.5
|
4.9
|
11.0
|
9.5
|
3.0
|
12.0
|
5.5
|
11.5
|
9.5
|
| JCA
|
32
|
4.2.98
|
14.0
|
10.0
|
10.0
|
9.0
|
4.0
|
15.9
|
12.0
|
12.2
|
10.5
|
| ODV
|
25
|
4.3.98
|
16.5
|
9.5
|
13.0
|
9.7
|
3.0
|
18.0
|
11.0
|
13.3
|
10.0
|
| PDS
|
22
|
10.6.98
|
14.4
|
8.3
|
11.0
|
7.8
|
3.0
|
15.8
|
9.0
|
11.6
|
8.3
|
| AGM
|
41
|
26.11.98
|
13.0
|
9.0
|
11.0
|
10.0
|
4.0
|
15.0
|
9.5
|
11.0
|
10.0
|
| MGF
|
32
|
29.9.97
|
12.5
|
5.5
|
12.5
|
10.0
|
4.0
|
14.5
|
8.0
|
13.0
|
10.0
|
| AHM
|
44
|
5.3.98
|
11.5
|
8.0
|
13.0
|
12.0
|
3.0
|
13.0
|
9.5
|
14.0
|
12.0
|
| AAMP
|
37
|
12.3.98
|
12.7
|
7.0
|
10.5
|
7.5
|
3.0
|
14.0
|
9.0
|
11.0
|
9.0
|
| JLMO
|
34
|
30.1.98
|
14.8
|
11.0
|
11.0
|
9.3
|
4.0
|
15.8
|
11.0
|
12.7
|
9.3
|
| JAMV
|
41
|
28.7.97
|
17.0
|
10.0
|
14.0
|
12.5
|
5.0
|
19.6
|
12.3
|
15.0
|
13.5
|
| FOR
|
8%
|
9.11.97
|
12.5
|
7.0
|
10.0
|
9.0
|
5.0
|
14.5
|
11.0
|
11.0
|
10.5
|
| ROM
|
28
|
12.11.97
|
16.0
|
8.5
|
13.0
|
9.0
|
5.0
|
18.0
|
12.5
|
13.5
|
10.5
|
| JPC
|
33
|
16.1.98
|
13.7
|
7.2
|
12.3
|
10.1
|
3.0
|
16.7
|
8.7
|
13.1
|
10.9
|
| JAPG
|
29
|
4.11.97
|
10.0
|
8.0
|
12.0
|
10.0
|
6.0
|
13.5
|
11.5
|
13.0
|
11.0
|
| FPR
|
8%
|
20.3.98
|
10.5
|
7.0
|
12.0
|
10.0
|
3.0
|
11.3
|
7.3
|
12.7
|
10.0
|
| JPF
|
42
|
23.3.98
|
13.0
|
7.0
|
13.0
|
10.0
|
3.0
|
14.5
|
8.5
|
13.0
|
10.5
|
| AJRF
|
26
|
28.11.97
|
14.0
|
9.0
|
13.0
|
9.0
|
4.0
|
16.0
|
10.7
|
13.0
|
10.0
|
| ARR
|
58
|
7.10.97
|
11.0
|
7.0
|
11.0
|
9.0
|
3.0
|
12.0
|
8.0
|
12.0
|
10.0
|
| RRG
|
25
|
25.11.97
|
14.5
|
11.0
|
11.0
|
10.0
|
3.0
|
15.0
|
12.4
|
11.7
|
10.8
|
| CSM
|
35
|
24.2.98
|
15.0
|
9.0
|
11.0
|
9.0
|
3.0
|
16.5
|
11.0
|
12.0
|
10.0
|
| ASE
|
35
|
20.3.98
|
12.5
|
7.5
|
11.5
|
9.0
|
4.0
|
14.5
|
9.5
|
12.5
|
10.5
|
| ASPA
|
42
|
7.11.97
|
14.0
|
7.5
|
12.0
|
9.0
|
4.0
|
16.0
|
9.5
|
13.0
|
10.5
|
| SSF
|
27
|
15.8.97
|
14.5
|
7.0
|
14.5
|
8.0
|
3.0
|
15.9
|
8.0
|
15.0
|
8.7
|
| ISB
|
22
|
23.9.97
|
11.5
|
7.5
|
11.0
|
9.5
|
4.0
|
13.5
|
10.2
|
11.3
|
10.3
|
| FT
|
53
|
19.11.97
|
14.5
|
10.0
|
13.0
|
10.0
|
3.0
|
16.0
|
11.5
|
13.5
|
10.5
|
| EVC
|
24
|
29.12.97
|
11.0
|
7.0
|
11.5
|
9.0
|
5.0
|
13.5
|
9.0
|
12.5
|
10.5
|
| PV
|
33
|
8.10.97
|
12.0
|
8.5
|
15.5
|
13.0
|
4.0
|
13.0
|
9.5
|
16.0
|
13.0
|
| JSVS
|
32
|
24.1.98
|
12.0
|
6.0
|
10.5
|
9.0
|
4.0
|
14.0
|
8.5
|
12.5
|
9.5
|
L-Erec1 = Length in Erection initial
L-Flac1 = Length in Flaccidity inicial
P-Erec1 = Perimeter in Erection initial
P-Flac1 = Perimeter in Flaccidity inicial
L-Erec2 = Length in Erection final
L-Flac2 = Length in Flaccidity final
P-Erec2 = Perimeter in Erection final
P-Flac2 = Perimeter in Flaccidity final
|
